Pharmacogenetic study of serotonin 6 rec
β
Taro Kishi; Yasuhisa Fukuo; Reiji Yoshimura; Tomo Okochi; Tsuyoshi Kitajima; Hir
π
Article
π
2010
π
John Wiley and Sons
π
English
β 73 KB
π 1 views
## Abstract ## Objective Several investigations have suggested that alterations in serotonin 6 (5βHT6) receptors might be associated with the pathophysiology of major depressive disorder (MDD), and that 5βHT6 receptors might be a therapeutic target for serotonin selective reuptake inhibitor (SSRI)